Francis Tally and the Discovery and Development of Tigecycline: A Personal ReminiscencePROJAN, Steven J.Clinical infectious diseases. 2010, Vol 50, issn 1058-4838, S24-S25, SUP1Conference Paper

Tigecycline : A critical analysisSTEIN, Gary E; CRAIG, William A.Clinical infectious diseases. 2006, Vol 43, Num 4, pp 518-524, issn 1058-4838, 7 p.Article

Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysisTASINA, Efthimia; HAIDICH, Anna-Bettina; KOKKALI, Stamatia et al.Lancet. Infectious diseases (print). 2011, Vol 11, Num 11, pp 834-844, issn 1473-3099, 11 p.Article

Proteomic analysis of the anti-inflammatory action of minocyclineDUNSTON, Christopher R; GRIFFITHS, Helen R; LAMBERT, Peter A et al.Proteomics (Weinheim. Print). 2011, Vol 11, Num 1, pp 42-51, issn 1615-9853, 10 p.Article

Off-label prescription of tigecycline: clinical and microbiological characteristics and outcomesCONDE-ESTEVEZ, David; GRAU, Santiago; PABLO HORCAJADA, Juan et al.International journal of antimicrobial agents (Print). 2010, Vol 36, Num 5, pp 471-472, issn 0924-8579, 2 p.Article

High Concentrations of Manganese in Mueller-Hinton Agar Increase MICs of Tigecycline Determined by EtestFERNANDEZ-MAZARRASA, Carlos; MAZARRASA, Olav; CALVO, Jorge et al.Journal of clinical microbiology (Print). 2009, Vol 47, Num 3, pp 827-829, issn 0095-1137, 3 p.Article

The in vitro evaluation of tigecycline tested against pathogens isolated in eight countries in the Asia-Western Pacific region (2008)FARRELL, David J; TURNIDGE, John D; BELL, Jan et al.The Journal of infection. 2010, Vol 60, Num 6, pp 440-451, issn 0163-4453, 12 p.Article

Clinical Pharmacokinetics and Pharmacodynamics of TigecyclineBARBOUR, April; SCHMIDT, Stephan; MA, Benjamin et al.Clinical pharmacokinetics. 2009, Vol 48, Num 9, pp 575-584, issn 0312-5963, 10 p.Article

Functional, biophysical, and structural bases for antibacterial activity of tigecyclineOLSON, Matthew W; RUZIN, Alexey; FEYFANT, Eric et al.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 6, pp 2156-2166, issn 0066-4804, 11 p.Article

Effects of efflux transporter genes on susceptibility of Escherichia coli to tigecycline (GAR-936)HIRATA, Takahiro; SAITO, Asami; NISHINO, Kunihiko et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 6, pp 2179-2184, issn 0066-4804, 6 p.Article

Pharmacokinetic/pharmacodynamic profile for tigecycline : a new glycylcycline antimicrobial agent : TigecyclineMEAGHER, Alison K; AMBROSE, Paul G; GRASELA, Thaddeus H et al.Diagnostic microbiology and infectious disease. 2005, Vol 52, Num 3, pp 165-171, issn 0732-8893, 7 p.Article

Tigecycline : A new glycylcycline for treatment of serious infectionsNOSKIN, Gary A.Clinical infectious diseases. 2005, Vol 41, Num 5, pp S303-S314, issn 1058-4838, SUPArticle

In vitro activities of tigecycline against clinical isolates from Shanghai, ChinaZHANG, Ying-Yuan; LE ZHOU; ZHU, De-Mei et al.Diagnostic microbiology and infectious disease. 2004, Vol 50, Num 4, pp 267-281, issn 0732-8893, 15 p.Article

Excess Deaths Associated With Tigecycline After Approval Based on Noninferiority TrialsPRASAD, Paritosh; JUNFENG SUN; DANNER, Robert L et al.Clinical infectious diseases. 2012, Vol 54, Num 12, pp 1699-1709, issn 1058-4838, 11 p.Article

Antimalarial Activity of Tigecycline, a Novel Glycylcycline AntibioticSTARZENGRUBER, P; THRIEMER, K; HAQUE, R et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 9, pp 4040-4042, issn 0066-4804, 3 p.Article

Tigecycline : what is it, and where should it be used?LIVERMORE, David M.Journal of antimicrobial chemotherapy (Print). 2005, Vol 56, Num 4, pp 611-614, issn 0305-7453, 4 p.Article

Comparative Evaluation of Tigecycline Susceptibility Testing Methods for Expanded-Spectrum Cephalosporin- and Carbapenem-Resistant Gram-Negative PathogensZARKOTOU, Olympia; POURNARAS, Spyros; ALTOUVAS, George et al.Journal of clinical microbiology (Print). 2012, Vol 50, Num 11, pp 3747-3750, issn 0095-1137, 4 p.Article

Trends in the Susceptibility of Clinically Important Resistant Bacteria to Tigecycline: Results from the Tigecycline In Vitro Surveillance in Taiwan Study, 2006 to 2010CHEN, Yen-Hsu; LU, Po-Liang; JANG, Tsrang-Neng et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 3, pp 1452-1457, issn 0066-4804, 6 p.Article

Differences in Determining In Vitro Tigecycline Susceptibility According to the Agar Medium UsedLEAL, A. L; BUITRAGO, G; OVALLE, M. V et al.Journal of chemotherapy (Testo stampato). 2010, Vol 22, Num 2, pp 137-138, issn 1120-009X, 2 p.Article

Evaluation of Etest To Determine Tigecycline MICs for Enterobacter SpeciesCOHEN STUART, James; MOUTON, Johan W; DIEDEREN, Bram M. W et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 6, pp 2746-2747, issn 0066-4804, 2 p.Article

Tigecycline : The answer to beta-lactam and fluoroquinolone resistance?FRAISE, Adam P.The Journal of infection. 2006, Vol 53, Num 5, pp 293-300, issn 0163-4453, 8 p.Article

Peritoneal fluid penetration of tigecyclineSCHEETZ, Marc H; REDDY, Pavani; NICOLAU, David P et al.The Annals of pharmacotherapy. 2006, Vol 40, Num 11, pp 2064-2067, issn 1060-0280, 4 p.Article

Activity of tigecycline tested against a global collection of enterobacteriaceae, including tetracycline-resistant isolates : TigecyclineFRITSCHE, Thomas R; STRABALA, Patty A; SADER, Helio S et al.Diagnostic microbiology and infectious disease. 2005, Vol 52, Num 3, pp 209-213, issn 0732-8893, 5 p.Article

Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000-2004) : TigecyclineFRITSCHE, Thomas R; SADER, Helio S; STILWELL, Matthew G et al.Diagnostic microbiology and infectious disease. 2005, Vol 52, Num 3, pp 195-201, issn 0732-8893, 7 p.Article

TigecyclinePANKEY, George A.Journal of antimicrobial chemotherapy (Print). 2005, Vol 56, Num 3, pp 470-480, issn 0305-7453, 11 p.Article